BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 26223657)

  • 21. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway.
    Komaravelli N; Ansar M; Garofalo RP; Casola A
    Free Radic Biol Med; 2017 Dec; 113():494-504. PubMed ID: 29107745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
    Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies.
    Geoffroy MC; Jaffray EG; Walker KJ; Hay RT
    Mol Biol Cell; 2010 Dec; 21(23):4227-39. PubMed ID: 20943951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
    Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
    Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.
    Han Y; Huang C; Sun X; Xiang B; Wang M; Yeh ET; Chen Y; Li H; Shi G; Cang H; Sun Y; Wang J; Wang W; Gao F; Yi J
    J Biol Chem; 2010 Apr; 285(17):12906-15. PubMed ID: 20181954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
    Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
    Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
    Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
    Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal.
    Riley BE; Zoghbi HY; Orr HT
    J Biol Chem; 2005 Jun; 280(23):21942-8. PubMed ID: 15824120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moloney murine leukemia virus integrase and reverse transcriptase interact with PML proteins.
    Okino Y; Inayoshi Y; Kojima Y; Kidani S; Kaneoka H; Honkawa A; Higuchi H; Nishijima K; Miyake K; Iijima S
    J Biochem; 2012 Aug; 152(2):161-9. PubMed ID: 22685230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
    Erker Y; Neyret-Kahn H; Seeler JS; Dejean A; Atfi A; Levy L
    Mol Cell Biol; 2013 Jun; 33(11):2163-77. PubMed ID: 23530056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.
    Gao C; Ho CC; Reineke E; Lam M; Cheng X; Stanya KJ; Liu Y; Chakraborty S; Shih HM; Kao HY
    Mol Cell Biol; 2008 Sep; 28(18):5658-67. PubMed ID: 18625722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation.
    Sohn SY; Hearing P
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6725-30. PubMed ID: 27247387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S; Udagawa O
    Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.